In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.

M. Eckes (Valognes, France), A. Paris (Valognes, France), B. Hervieu (Valognes, France), A. Vanlaeys (Valognes, France), K. Housseini (Valognes, France), T. Porée (Valognes, France)

Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Session: Paediatrics and Quality of life
Session type: Poster Discussion
Number: 122
Disease area: Respiratory critical care

Congress or journal article abstractPDF journal article, handout or slidesE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Eckes (Valognes, France), A. Paris (Valognes, France), B. Hervieu (Valognes, France), A. Vanlaeys (Valognes, France), K. Housseini (Valognes, France), T. Porée (Valognes, France). In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.. Respiratory Failure and Mechanical Ventilation Conference 2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
In vitro evaluation of spacers in comparison with T-adapters in mechanical ventilation with pressurized metered dose inhalers (pMDI) and vibrating mesh nebulizer.
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019

In vitro comparison of aerosol characteristics of HFA albuterol (salbutamol) pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs)
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011

In vitro comparison of aerosol characteristics of HFA ipratropium bromide pressurized metered dose inhaler (pMDI) formulation from three valved holding chambers (VHCs)
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I
Year: 2011

In vitro comparison of output and particle size distribution of budesonide from metered-dose inhaler with three spacer devices during pediatric tidal breathing
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005

The in vitro fine particle dose with Symbicort Rapihaler pMDI is similar using either NebuChamber or AeroChamber Plus valved holding chamber spacer devices
Source: Eur Respir J 2005; 26: Suppl. 49, 504s
Year: 2005

Impact of inhalation delay on medication delivery from a salbutamol HFA pressurized metered dose inhaler used with and without a new prototype portable valved holding chamber
Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies
Year: 2019

Valved holding chamber (VHC) angle can affect pressurized netered-dose inhaler (pMDI) medication delivery efficiency
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018




Assessment of the suitability of filters for use in clinical studies with an HFA fluticasone propionate pressurized metered dose inhaler (pMDI) and a valved holding chamber (VHC)
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011

Comparison of proficiency of pressurized metered dose inhaler (pMDI) use with asthma control
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Pressurised metered dose inhalers (pMDIs) with integrated flow rate guidance.
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017


Two-tone trainer maintains a slow inhalation rate when using a metered dose inhaler (MDI)
Source: Eur Respir J 2005; 26: Suppl. 49, 47s
Year: 2005

A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


In vitro testing of an improved collapsible valved holding chamber (CHC) with a pressurized metered-dose inhaler delivered bronchodilator, simulating an adult mechanically ventilated patient
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010


In vitro equivalence exists for infant non-conducting (NC) and anti-static (AS) valved holding chambers (VHC) from the same family of add on devices used with pressurized metered dose inhalers (pMDIs) provided pre-conditioning of the non-conducting VHCs is undertaken
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


In vitro evaluation of a new spacer for pMDI and nebulizers in mechanical ventilation
Source: Annual Congress 2012 - Multidisciplinary critical care
Year: 2012


Aerosol characterization of three corticosteroids in MDIs plus a new spacer device (Fluspacer®) vs MDIs alone
Source: Eur Respir J 2001; 18: Suppl. 33, 101s
Year: 2001

Comparison of a dry powder inhaler (DPI) to a pressurized metered-dose inhaler (pMDI) formulation of extra fine beclomethasone dipropionate/formoterol fumarate/glycopyrronium bromide (BDP/FF/GB) in patients with COPD: The TRI-D study.
Source: Virtual Congress 2020 – COPD : inhaled corticosteroids, bronchodilators and eosinophils
Year: 2020


Albuterol delivery by soft mist and pressurized metered dose inhalers during noninvasive ventilation in a model of a spontaneously breathing child
Source: International Congress 2018 – Neonatology and paediatric intensive care
Year: 2018


Technique training doesn‘t improve patients ability to use pressurised metered dose inhalers (pMDIs)
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009


The impact of different valved holding chambers (VHCs) on lung drug delivery: using functional respiratory imaging (FRI) and a single metered dose inhaler (MDI) type
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020